Action of podophyllic acid on malignant tumors. II. Effects of podophyllic acid ethyl hydrazide on the incorporation of precursors into the nucleic acids of mouse mammary tumors and livers in vivo.
D000225:Adenine / Q000378:metabolism*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002247:Carbon Isotopes; D004247:DNA / Q000096:biosynthesis*; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D003864:Depression, Chemical; D006834:Hydrazines / Q000494:pharmacology; D008099:Liver / Q000378:metabolism*; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism*; D051379:Mice; D009705:Nucleosides / Q000378:metabolism*; D010710:Phosphates / Q000378:metabolism*; D010759:Phosphorus Isotopes; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin; D011035:Podophyllum; D012313:RNA / Q000096:biosynthesis*; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D013936:Thymidine / Q000378:metabolism*; D014316:Tritium; D014529:Uridine / Q000378:metabolism*
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D006834:Hydrazines; D009705:Nucleosides; D010710:Phosphates; D010759:Phosphorus Isotopes; D012334:RNA, Neoplasm; D014316:Tritium; D012313:RNA; D011033:Podophyllin; D004247:DNA; D000225:Adenine; D013936:Thymidine; D014529:Uridine